Nanotechnology Now

Our NanoNews Digest Sponsors





Heifer International

Wikipedia Affiliate Button


android tablet pc

Home > Press > Berkeley Lab Awarded $12.8 Million in Stimulus Funds for Health Research

Abstract:
$4.2 million to test treatments for victims of possible nuclear terrorism

Berkeley Lab Awarded $12.8 Million in Stimulus Funds for Health Research

Berkeley, CA | Posted on January 20th, 2010

Lawrence Berkeley National Laboratory has been awarded $12.8 million in American Recovery and Reinvestment Act funding by the National Institutes of Health (NIH) for research into cancer, neurodegenerative diseases, radioactive decontamination and a variety of other health conditions.

The grants bring Berkeley Lab's total Recovery Act funding to more than $240 million in areas covering energy, computing and general science, as well as infrastructure projects. The NIH grants will go to 14 individual research projects ranging from disease investigation to the development of tools for medical researchers.

"The Recovery Act grants from NIH have allowed us to create quite a few new positions for scientists, technicians, research associates and postdoctoral fellows, as well as retain some jobs," said Joe Gray, Associate Laboratory Director for Life Sciences. "We're helping to train the nation's next generation of scientists while also doing important research in critical areas of human health that we may not have been able to do without these funds."

The largest individual award is $4.2 million for a two-year research project to develop treatments for contamination by radioactive actinide particles, such as those from fallout from a nuclear accident or a so-called "dirty bomb." Berkeley Lab's Glenn T. Seaborg Center (GTSC) has been working for years on oral therapeutics to treat internal actinide contamination, and this work has taken on more urgency in recent years as threats of nuclear terrorism have become more plausible. Previously, the main at-risk population had been nuclear power plant and defense workers.

The only existing method of mitigating risks of actinide contamination is a treatment developed in the 1950s that must be given through an injection, which would not be viable in a situation where residents of an entire metropolitan area must be injected in a matter of hours. Further, this agent, known as DTPA, is effective only on a few actinides.

Two molecules that have been developed at Berkeley Lab to sequester actinides can target a much wider range of actinides, the most well-known of which are uranium and plutonium. Contamination can cause acute cellular and tissue damage leading to cancer. Berkeley Lab's compounds would help excrete up to 90 percent of the radioactive particles within 24 hours, and given doses over subsequent days, nearly complete excretion is possible, the researchers say.

"The ARRA funding will enable us to proceed with pre-clinical development of two compounds that have been designed and tested," says scientist Rebecca Abergel. "They are very promising. We have not observed major toxicity issues, and the efficacy is in the range we want it to be. What we want to accomplish in the next two years is to gather data to get approval from the Food and Drug Administration."

The Berkeley Lab research group, led by GTSC Director Kenneth Raymond, will partner with SRI International and the Lovelace Respiratory Research Institute to conduct testing, including toxicology and pharmacology tests, with the goal of filing an investigational new drug application with the FDA in two years.

Other Recovery Act awards to Berkeley Lab from NIH include:

* $1.4 million to better understand a molecular switch in RNA splicing that occurs in red cell precursors. Understanding RNA splicing is important because proper splicing is essential for normal development; conversely, aberrant splicing is a common cause of genetic disease and a factor in many human cancers. The principal investigator (PI) is John Conboy.

* $1 million to develop tools to better understand the role of mitochondrial dysfunction in neurodegenerative diseases, including Alzheimer's disease, Parkinson's disease, and Huntington's disease, which together afflict at least one out of every 50 Americans. These three diseases share the property that mitochondria are not keeping up with the energy demands of the cell. The PIs are Cynthia McMurray and Trent Northen.

* $861,034 to investigate how red blood cell production is increased in response to multiple inherited and acquired anemias, including thalassemia, sickle cell disease, hereditary membrane disorders, autoimmune red blood cell destruction, and blood loss. The PI is Joel Chasis.

* $842,908 to develop a model to uncover the mechanism by which a certain noncoding region of the human genome confers susceptibility to cardiovascular or coronary artery disease, one of the major causes of mortality in the U.S. and the developed world. Researchers in the Genomics Division have identified a strong link between a noncoding region of the human genome and susceptibility to CAD. The PI is Len Pennacchio.

* $783,397 to complete a four-year project to map chromosomal proteins in the genome of the fruit flies. This project is highly likely to provide information critical to understanding the roles of chromatin in human cells and diseases, including cancer. The PI is Gary Karpen.

* $433,476 to build a next-generation robotic system for the study of biological molecules and their assemblies. The PI is Thomas Earnest.

* $366,123 to accelerate the development of the PHENIX software program, which automates crystallography data analysis, and the process of understanding the three-dimensional structure of proteins and nucleic acids. The PI is Paul Adams.

* $325,975 to investigate the roles of the SATB1 protein in the progression of different types of cancer and proteins functionally related to SATB1 in self-renewal and differentiation of embryonic stem cells. The PI is Terumi Kohwi-Shigematsu.

* $278,332 for the Berkeley Cancer Genome Center to systematically analyze the transcriptomes of human brain, ovarian and lung cancer with emphasis on discovering alternately spliced genes. This effort contributes to The Cancer Genome Altas project. The PI is Joe Gray.

####

About Berkeley Lab
Berkeley Lab is a U.S. Department of Energy national laboratory located in Berkeley, California. It conducts unclassified scientific research for DOE’s Office of Science and is managed by the University of California.

For more information, please click here

Contacts:
Julie Chao

510-486-6491

Copyright © Berkeley Lab

If you have a comment, please Contact us.

Issuers of news releases, not 7th Wave, Inc. or Nanotechnology Now, are solely responsible for the accuracy of the content.

Bookmark:
Delicious Digg Newsvine Google Yahoo Reddit Magnoliacom Furl Facebook

Related News Press

News and information

Harris & Harris Group to Host Conference Call on Second-Quarter 2014 Financial Results on August 15, 2014 July 23rd, 2014

UCF Nanotech Spinout Developing Revolutionary Battery Technology: Power the Next Generation of Electronics with Carbon July 23rd, 2014

Deadline Announced for Registration in 7th Int'l Nanotechnology Festival in Iran July 23rd, 2014

A Crystal Wedding in the Nanocosmos July 23rd, 2014

Jobs

Secretary Vilsack Announces Partnership to Advance Commercial Potential of Cellulosic Nanomaterial from Wood December 11th, 2013

Cutting Away at the NRC's Research Capability December 6th, 2013

Project aims to mass-produce 'nanopetals' for sensors, batteries October 22nd, 2013

Governor Cuomo Announces 'Nano Utica' $1.5 Billion Public-Private Investment That Will Make the Mohawk Valley New York's Next Major Hub of Nanotech Research October 12th, 2013

Govt.-Legislation/Regulation/Funding/Policy

NNCO Announces an Interactive Webinar: Progress Review on the Coordinated Implementation of the National Nanotechnology Initiative 2011 Environmental, Health, and Safety Research Strategy July 23rd, 2014

Nano-sized Chip "Sniffs Out" Explosives Far Better than Trained Dogs: TAU researcher's groundbreaking sensor detects miniscule concentrations of hazardous materials in the air July 23rd, 2014

NIST shows ultrasonically propelled nanorods spin dizzyingly fast July 22nd, 2014

Penn Study: Understanding Graphene’s Electrical Properties on an Atomic Level July 22nd, 2014

Nanomedicine

Researchers create vaccine for dust-mite allergies Main Page Content: Vaccine reduced lung inflammation to allergens in lab and animal tests July 22nd, 2014

NIST shows ultrasonically propelled nanorods spin dizzyingly fast July 22nd, 2014

SentiMag® Now Available in Australia and New Zealand July 21st, 2014

More than glitter: Scientists explain how gold nanoparticles easily penetrate cells, making them useful for delivering drugs July 21st, 2014

Announcements

Harris & Harris Group to Host Conference Call on Second-Quarter 2014 Financial Results on August 15, 2014 July 23rd, 2014

UCF Nanotech Spinout Developing Revolutionary Battery Technology: Power the Next Generation of Electronics with Carbon July 23rd, 2014

Deadline Announced for Registration in 7th Int'l Nanotechnology Festival in Iran July 23rd, 2014

A Crystal Wedding in the Nanocosmos July 23rd, 2014

Nanobiotechnology

Production of Non-Virus Nanocarriers with Highest Amount of Gene Delivery July 17th, 2014

Physicists Use Computer Models to Reveal Quantum Effects in Biological Oxygen Transport: The team solved a long-standing question by explaining why oxygen – and not deadly carbon monoxide – preferably binds to the proteins that transport it around the body. July 17th, 2014

Tiny DNA pyramids enter bacteria easily -- and deliver a deadly payload July 9th, 2014

Artificial cilia: Scientists from Kiel University develop nano-structured transportation system July 4th, 2014

NanoNews-Digest
The latest news from around the world, FREE



  Premium Products
NanoNews-Custom
Only the news you want to read!
 Learn More
NanoTech-Transfer
University Technology Transfer & Patents
 Learn More
NanoStrategies
Full-service, expert consulting
 Learn More














ASP
Nanotechnology Now Featured Books




NNN

The Hunger Project







© Copyright 1999-2014 7th Wave, Inc. All Rights Reserved PRIVACY POLICY :: CONTACT US :: STATS :: SITE MAP :: ADVERTISE